Back to Trades
Total Value
$18.7K
Net $16.6K sold
Filing Date
Jul 10, 2026
2 transactions
Sales
$16.6K
2 transactions
Trade Summary
On Jul 8, 2026 through Jul 9, 2026, Lorrain Daniel S., Chief Scientific Officer, sold $18.7K of Contineum Therapeutics, Inc. (CTNM) across 2 transactions. The filing covers Class A Common Stock and reflects net selling of $16.6K. Reported prices ranged from $1.01 to $16.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Contineum Therapeutics, Inc.
- Ticker Symbol
- CTNM
- CIK
- 0001855175
Insider Information
- Role
- Chief Scientific Officer
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001628280-26-047909
- Form Type
- 4
- Net Trading Amount
- -$16.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Class A Common Stock | 1,015 | $1.01 | Exercise | $1.0K |
| Jul 8, 2026 | Class A Common Stock | 1,015 | $16.00 | Sale | $16.2K |
| Jul 9, 2026 | Class A Common Stock | 25 | $1.01 | Exercise | $25 |
| Jul 9, 2026 | Class A Common Stock | 25 | $16.00 | Sale | $400 |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | CTNM derivative | 1,015 | $1.01 | Exercise | $1.0K |
| Jul 9, 2026 | CTNM derivative | 25 | $1.01 | Exercise | $25 |
Want live alerts when Lorrain Daniel S. trades again?
Download Insider Trades to track CTNM, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.
- (F2)The stock options are fully vested and exercisable.